Curi Bio
Curi Bio develops human-relevant platforms integrating human cells, systems, and data to accelerate the discovery of new medicines.
$10M Series B+ ·
Led by DreamCIS · Source: fundraisingfox.com
Total raised: $26M across 3 sourced rounds
All 3 rounds ↓Signals
About Curi Bio
Curi’s human iPSC-based products and services enable scientists to build mature and predictive human iPSC-derived tissues—with a focus on cardiac, musculoskeletal, and
Curi Bio | 2095 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $10M | fundraisingfox.com | ||
| Series A | $10M | fundraisingfox.com | ||
| Series A | $6M | curibio.com |
Timeline
- Website created
- X account created
Founders and team
EF
Elliot Fisher FounderHC
Heejoon Choi Director of Sales and MarketingAJ
Alex Jiao VP of R&DMC
Michael Cho Chief Executive OfficerNG
Nicholas Geisse Chief Executive OfficerWL
Wonil Lee Vice President of Research and Commercialization
Acquisitions
| Acquired company | Price | Announced |
|---|---|---|
| Not disclosed publicly | ||
| Not disclosed publicly | Date not given | |
| Not disclosed publicly | Date not given |
Investors
DDreamCISlead investor
DDS Asset Management
DDynamk Capitallead investor
NNational Institutes of Health
UUTC Investment Co.
Companies like Curi Bio
FFluoSphera$1.46M Seed · Jan 2026
IInfinimmuneSeries A
RReCode TherapeuticsSeries B+ · Oct 2023AAraceli Biosciences$4.5M Seed · Nov 2026
MMindpeak$15.3M Series A · Oct 2024
MManifold Bio$40M Series A · Jun 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/curi-bio (get a free API key).